Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Juan Jesus Rodriguez‐Uranga"'
Autor:
Mar Carreño, Antonio Gil‐Nagel, José M. Serratosa, Manuel Toledo, Juan Jesus Rodriguez‐Uranga, Vicente Villanueva
Publikováno v:
Epilepsia Open, Vol 9, Iss 3, Pp 1051-1058 (2024)
Abstract Objective Cenobamate is an antiseizure medication (ASM) associated with high rates of seizure freedom and acceptable tolerability in patients with focal seizures. To achieve the optimal cenobamate dose for maximal potential effectiveness whi
Externí odkaz:
https://doaj.org/article/a918501ee9b846fbb730989b8c291bc6
Publikováno v:
Epilepsia Open, Vol 9, Iss 4, Pp 1345-1356 (2024)
Abstract Objective This study aimed to explore the impact of co‐antiseizure medication (co‐ASM) optimization on the effectiveness and tolerability of adjunctive cenobamate (CNB) in patients with drug‐resistant epilepsy in a real‐world setting
Externí odkaz:
https://doaj.org/article/ee6ccf9879c2430abdc141dd966533b4
Autor:
Claudio Liguori, Estevo Santamarina, Adam Strzelczyk, Juan Jesús Rodríguez-Uranga, Rohit Shankar, Xiana Rodríguez-Osorio, Stéphane Auvin, Paolo Bonanni, Eugen Trinka, Rob McMurray, Ricardo Sáinz-Fuertes, Vicente Villanueva
Publikováno v:
Frontiers in Neurology, Vol 14 (2023)
IntroductionThe PERMIT study is the largest pooled analysis of perampanel (PER) clinical practice data conducted to date.MethodsThis post-hoc analysis of PERMIT investigated the effectiveness, safety and tolerability of PER when used as early add-on
Externí odkaz:
https://doaj.org/article/1d156cae057a4f7181f5a1605d5679ea